Skip to main navigation Skip to search Skip to main content

Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross-sectional observational study

  • Friedemann Erchinger*
  • , Erling Tjora
  • , Ingrid Kvåle Nordaas
  • , Georg Dimcevski
  • , Søren Schou Olesen
  • , Nanna Jensen
  • , Eva Efsen Dahl
  • , Anders Borch
  • , Camilla Nøjgaard
  • , Srdan Novovic
  • , Giedrus Barauskas
  • , Povilas Ignatavicius
  • , Miroslav Vujasinovic
  • , Matthias Lőhr
  • , Johanna Laukkarinen
  • , Mikael Parhiala
  • , Asbjørn Mohr Drewes
  • , Trond Engjom
  • *Corresponding author for this work

    Research output: Contribution to journal › Article › Scientific › peer-review

    18 Citations (Scopus)
    35 Downloads (Pure)

    Abstract

    Objectives: Pancreatic exocrine insufficiency (PEI) is a common complication in patients with chronic pancreatitis (CP), leading to increased morbidity and mortality if not treated adequately. Pancreatic enzyme replacement therapy|pancreas enzyme replacement therapy (PERT) is the cornerstone in treatment of patients with PEI. In the present study, we use data from the Scandinavian Baltic Pancreatic Club database to examine adherence of PERT according to United European Gastroenterology evidence-based guidelines treatment of CP. Patients and methods: Patients with definitive or probable CP according to M-ANNHEIM diagnostic criteria were included. We collected information on exposures, exocrine function, intake of pancreatic enzymes, and markers of nutrition. Fecal elastase <200 μg/g was defined as a marker for PEI. Enzyme replacement therapy of 100,000 lipase units or more was defined as adequate treatment. Results: We included 1006 patients from 8 centers in five countries. Sixty-four percent of the patients were correctly treated. Twenty-five per cent of PEI patients were not taking enzymes at all, and 20% of PEI patients were undertreated with insufficient PERT doses according to the guidelines. Fourteen percent of patients with sufficient pancreatic function were receiving enzymes despite normal exocrine pancreatic function. There were center differences. Current smoking was associated with lack of treatment and alcohol abuse was associated with under-treatment. There were no associations between “no treatment” or “under-treatment” for underweight or vitamin D deficiency. Conclusion: In our CP expert centers, the adherence to guidelines for enzyme treatment is insufficient. Both patient factors and center differences have influence on treatment adherence.

    Original languageEnglish
    Article number12276
    JournalUnited European Gastroenterology Journal
    Volume10
    Issue number8
    DOIs
    Publication statusPublished - 2022
    Publication typeA1 Journal article-refereed

    Keywords

    • chronic pancreatitis
    • pancreatic enzyme replacement therapy
    • pancreatic exocrine insufficiency
    • scandinavian baltic pancreatic club
    • United European Gastroenterology

    Publication forum classification

    • Publication forum level 1

    Fingerprint

    Dive into the research topics of 'Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross-sectional observational study'. Together they form a unique fingerprint.

    Cite this